FDA busts Concordia on phone marketing violation; Lundbeck launches Selincro in Spain;

> A professional telephone script used by Concordia Pharmaceuticals to market its extended-released Kapvay tablets has violated the FDA's advertising regulations, the agency says. More

> Lundbeck has launched alcohol dependence med Selincro in Spain. Release

> Merck ($MRK) and the Positive Women's Network have teamed up for national HIV campaign "I Design." Story

> Quintiles ($Q) will commercialize Basilea Pharmaceutica's antibiotic Zevtera/Mabelio in Europe. Report

> Galena Biopharma has licensed the U.S. rights for oral soluble film Zuplenz. Release

> Arena Pharma ($ARNA) and Teva ($TEVA) have inked a marketing and supply deal for obesity drug Belviq in Israel. More

> Anacor Pharmaceuticals ($ANAC) and Novartis' ($NVS) Sandoz have entered a commercialization agreement for topical solution Kerydin in the United States. Release

And Finally... Eisai has launched Chocola BB Royal Drink, designed to promote beauty and wellness, in China. More

Suggested Articles

Eli Lilly bought full-page ads in more than a dozen newspapers in the U.S. to let people with diabetes who use Lilly drugs to know help is available.

Only months after a game-changing new approval for Vascepa, Amarin has lost a key fight over its patents—and now it's scrambling to respond.

Move over, Roche. There’s a new small cell lung cancer therapy on the scene, and it belongs to AstraZeneca.